Knack RCM Unveils AI-Native Anesthesia Revenue Cycle Platform
WOODBRIDGE, N.J., July 29, 2026 Knack RCM has highlighted its specialty-intelligent, AI-native anesthesia revenue cycle management platform, combining more...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WOODBRIDGE, N.J., July 29, 2026 Knack RCM has highlighted its specialty-intelligent, AI-native anesthesia revenue cycle management platform, combining more...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
SECAUCUS, N.J., Feb. 23, 2026 — The Vitamin Shoppe announced the launch of its inaugural “Suppies” Awards, a new...
PALO ALTO, USA & MULGRAVE, Australia, Feb. 20, 2026 — Gyder Surgical announced the first commercial surgical cases in...
